Intensive BP Treatment Appears Safe, Well Tolerated

Share this content:
Intensive BP Treatment Appears Safe, Well Tolerated
Intensive BP Treatment Appears Safe, Well Tolerated

THURSDAY, Aug. 24, 2017 (HealthDay News) -- For patients at increased risk of cardiovascular disease, intensive blood pressure control may be just as safe as standard treatment, and is likely cost-effective, according to a study published in the Aug. 24 issue of the New England Journal of Medicine.

Dan Berlowitz, M.D., M.P.H., chief of staff at the Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Mass., and colleagues used information collected from 9,361 patients during the SPRINT trial. At the start of the study and then yearly, patients completed standard surveys on day-to-day well-being. They rated their physical and mental health, satisfaction with their care, and ability to adhere to their medication.

On average, the researchers found, patients on intensive treatment fared as well as those on standard care. That was true even among elderly, frail patients.

A second study in the same journal issue looked at cost. Researchers used a mathematical model to estimate the costs of additional blood pressure medication, extra doctor visits, and treatment for any adverse effects of intensive blood pressure control. They weighed that against the potential savings from prevention of cardiovascular disease events. The investigators found that intensive treatment cost well below $50,000 for every quality-adjusted life-year gained.

Abstract/Full Text 1 (subscription or payment may be required)
Abstract/Full Text 2 (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC Launches Campaign to Fight Prescription Opioid Epidemic

CDC Launches Campaign to Fight Prescription Opioid Epidemic

Rx Awareness campaign uses testimonials to educate the public, increase awareness about risks

Liraglutide Linked to Reduction in VAT, Improvement in -Index

Liraglutide Linked to Reduction in VAT, Improvement in ...

Significant improvement in IGF-II serum levels with liraglutide for obese with prediabetes, early T2DM

Nut Consumption Linked to Nutritionally Rich Food Intake

Nut Consumption Linked to Nutritionally Rich Food Intake

Nut consumers eat more fruits, vegetables, less red meat, and have lower BMI than non-nut consumers

is free, fast, and customized just for you!

Already a member?

Sign In Now »